Amy Cabrera
Hematology & Oncology · Canovanas, PRNPI 1831454123
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for hematology & oncology clinicians in PR, where the typical reported total is $10,882.
Across 61 payments — averaging $21.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$259
- AstraZeneca$217
- Amgen$111
- Johnson & Johnson$82
- Merck$81
- Genentech USA, Inc.$79
- plus $467 from 15 others
What the payments were for
- Food & beverage$1,296100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 11 | $259 |
| AstraZeneca | 10 | $217 |
| Amgen | 5 | $111 |
| Johnson & Johnson | 4 | $82 |
| Merck | 4 | $81 |
| Genentech USA, Inc. | 5 | $79 |
| Novartis | 3 | $64 |
| Eli Lilly Export S.A. Puerto Rico Branch | 3 | $64 |
| Clovis Oncology, Inc. | 3 | $62 |
| GSK | 2 | $37 |
| Seagen Inc. | 1 | $29 |
| Sanofi | 1 | $26 |
| AbbVie | 1 | $25 |
| PBG Puerto Rico LLC | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Incyte Corporation | 1 | $25 |
| Puma Biotechnology, Inc. | 1 | $23 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $20 |
| Exelixis Inc. | 1 | $17 |
| Pfizer Pharmaceuticals LLC | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
How this compares
$1,296 in reported general payments places this provider in the 15th percentile of 138 hematology & oncology providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BosulifBosutinib | 11 | $215,220 |
| IbrancePalbociclib | 13 | $208,187 |
| FulphilaPegfilgrastim-Jmdb | 11 | $23,224 |
| Anastrozole | 201 | $3,157 |
| Exemestane | 29 | $1,812 |
| Hydroxyurea | 38 | $1,131 |
| Letrozole | 54 | $1,039 |
| Ondansetron Hcl | 30 | $460 |
| Famotidine | 54 | $272 |
| Gabapentin | 21 | $204 |
| Omeprazole | 24 | $183 |
| Montelukast Sodium | 22 | $129 |
| Dexamethasone | 13 | $91 |
| Prednisone | 12 | $51 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Canovanas
- Alexis Cruz ChaconSan Juan$450K
- Jose Lozada CostasSan Juan$260K
- Cristian Rodriguez ArochoSan Juan$227K
- Noridza Rivera RodriguezSan Juan$177K
- Joel Lopez-FigueroaHumacao$163K
- Mirelis AcostaSan Juan$154K
- Luis Baez VallecilloSan Juan$107K
- Carlos Mendez SerranoCaguas$91K
- Santa MerleMoca$84K
- Edgardo Santiago-GuzmanSan Juan$79K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.